ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662251 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662251; 2) Community: the network communities that were significantly associated with the response to NSC 662251; 3) Molecule: the relationships between components within communities and NSC 662251; 4) MDR: the compounds that were significantly associated with the NSC 662251.

NSC Compound Enrichment Correlation
NSC 624166 Null 0.00888636978630788 0.36772967
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.00888636978630788 0.41891254
NSC 628560 Null 0.00888636978630788 0.21510139
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.00888636978630788 0.39598048
NSC 634766 Null 0.00888636978630788 0.23094312
NSC 662116 4H-Cyclopenta[c]thiophen-4-one, 6-amino-1,3-dibromo- 5,6-dihydro-, hydrochloride 0.00888636978630788 0.30732759
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0102077332082016 0.43810047
NSC 699921 Null 0.0102077332082017 0.34222282
NSC 81052 Streptonigrin analog (MeO-N3) 0.0102077332082017 0.43887226
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0102962192514438 0.13726316
Total:93  Current:22    [First] [Prev] [Next] [Last]